2,675
Views
0
CrossRef citations to date
0
Altmetric
Obesity

Recommendations for the prevention and management of obesity in the Iraqi population

, , , , , , , , , , , , , , & show all
Pages 425-439 | Received 28 Sep 2022, Accepted 23 Jan 2023, Published online: 18 Feb 2023

References

  • WHO. Obesity and overweight. Published 2021. Accessed September 13, 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  • AMA. Report of the council on science and public health - report 3-A-13. Accessed September 13, 2021. https://www.ama-assn.org/sites/ama-assn.org/files/corp/media-browser/public/about-ama/councils/Council Reports/council Reports/councilonsciencepublichealth/a13csaph3.pdf
  • Bays H, Seger J, Primack C, et al. Obesity Algorithm, presented by the Obesity Medicine Association. Accessed September 13, 2021. https://www.amga.org/amga/media/pdfs/performance improvement and publications/best practices and analytics/learning collaboratives/obesity care model/oma_obesity improvement and publications/best practices and analytics/learning collaboratives/obesity care model/oma_obesityalgorithm.pdf
  • Dai H, Alsalhe TA, Chalghaf N, et al. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: an analysis of the global burden of disease study. Wareham NJ, ed. PLOS Med. 2020;17(7):e1003198.
  • Murray CJL, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223–1249.
  • Felisbino-Mendes MS, Cousin E, Malta DC, et al. The burden of non-communicable diseases attributable to high BMI in Brazil, 1990–2017: findings from the global burden of disease study. Popul Heal Metrics. 2020;18(1):1–13.
  • Bhaskaran K, dos-Santos-Silva I, DA L, et al. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944–953.
  • Collaboration PS. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–1096.
  • Rozjabek H, Fastenau J, LaPrade A, et al. and Health-Related Quality of Life, Patient Activation, Work Productivity, and Weight Loss Behaviors in the United States. Diabetes, Metab Syndr Obes Targets Ther. 2020;13:2049.
  • Kolotkin RL, Andersen JR. A systematic review of reviews: exploring the relationship between obesity, weight loss and health‐related quality of life. Clin Obes. 2017;7(5):273.
  • Nikoloski Z, Williams G. Metabolic Syndrome. In: Ahima RS, editor. Obesity in Middle East. Springer International Publishing; 2016. p. 55–72. DOI:10.1007/978-3-319-11251-0_6.
  • Ministry of Health/Directorate of Public Health, Ministry of Planning/Central Statistical Organization, World Health Organization. Non-Communicable Diseases Risk Factors STEPS Survey Iraq 2015; 2015. Accessed September 13, 2021. https://untobaccocontrol.org/impldb/wp-content/uploads/iraq_2018_annex-1_STEPS_report_2015.pdf
  • Wharton S, Lau DCW, Vallis M, et al. Obesity in adults: a clinical practice guideline. Can Med Assoc J. 2020;192(31):E875–E891.
  • Yumuk V, Tsigos C, Fried M, et al. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8(6):402.
  • Ma C, Avenell A, Bolland M, et al. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ. 2017;359:j4849.
  • Haase CL, Lopes S, Olsen AH, et al. Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes. 2021;45(6):1249–1258.
  • Kritchevsky SB, Beavers KM, Miller ME, et al. Intentional Weight Loss and All-Cause Mortality: a Meta-Analysis of Randomized Clinical Trials. PLoS One. 2015;10(3):3.
  • LeBlanc ES, Patnode CD, Webber EM, et al. Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018;320(11):1172–1191. doi:10.1001/JAMA.2018.7777
  • Zaghloul H, Elshakh H, Elzafarany A, et al. A systematic review of randomized controlled trials of dietary interventions for weight loss in adults in the Middle East and north Africa region. Clin Obes. 2021;11(2):2.
  • Gupta N, Bombak A, Foroughi I, et al. Evidence-based recommendations to assist adults with depression to become lifelong movers. Heal Promot Chronic Dis Prev Canada. 2020;40(11/12):329–335.
  • Althumiri NA, Basyouni MH, AlMousa N, et al. Exploring weight stigma in Saudi Arabia: a nationwide cross-sectional study. Int J Environ Res Public Health. 2021;18(17):9141.
  • Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26(4):485–497.
  • Tomiyama AJ, Carr D, Granberg EM, et al. How and why weight stigma drives the obesity ‘epidemic’ and harms health. BMC Med. 2018;16(1):123.
  • Althumiri NA, Basyouni MH, BinDhim NF, et al. Levels and Associations of Weight Misperception with Healthy Lifestyle among Adults in Saudi Arabia. Obes Facts. 2021 September 14;1–7. doi:10.1159/000518633 Published online
  • Zhu SK, Wang ZM, Heshka S, et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr. 2002;76(4):743–749.
  • Ross R, Neeland IJ, Yamashita S, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16(3):177–189.
  • Heart N, Institute B. Managing Overweight and Obesity in Adults Systematic Evidence Review From the Obesity Expert Panel, 2013. Published online 2013.
  • Mansour AA, Al-Hassan AA, Al-Jazairi MI. Cut-off values for waist circumference in rural Iraqi adults for the diagnosis of metabolic syndrome. Rural Remote Health. 2007;7(4):765.
  • Valk ES, Akker ELT, Savas M, et al. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obes Rev. 2019;20(6):795–804.
  • Vaisse C, Clement K, Durand E, et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest. 2000;106(2):253–262.
  • Farooqi IS, Yeo GSH, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 2000;106(2):271–279.
  • Hainerová I, Larsen LH, Holst B, et al. Melanocortin 4 Receptor Mutations in Obese Czech Children: studies of Prevalence, Phenotype Development, Weight Reduction Response, and Functional Analysis. J Clin Endocrinol Metab. 2007;92(9):3689–3696.
  • Saeed S, Bonnefond A, Manzoor J, et al. Genetic variants in LEP, LEPR, and MC4R explain 30% of severe obesity in children from a consanguineous population. Obesity (Silver Spring). 2015;23(8):1687–1695.
  • Farooqi IS, Keogh JM, Yeo GSH, et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348(12):1085–1095.
  • Vollbach H, Brandt S, Lahr G, et al. Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort. Int J Obes (Lond). 2017;41(1):13–22.
  • Branson R, Potoczna N, Kral JG, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med. 2003;348(12):1096–1103.
  • Greenfield JR, Miller JW, Keogh JM, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med. 2009;360(1):44–52.
  • Iepsen EW, Zhang J, Thomsen HS, et al. Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist. Cell Metab. 2018;28(1):23–32.e3.
  • Iepsen EW, Have CT, Veedfald S, et al. GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: a Case Report. Cell Reports Med. 2020;1(1):1.
  • Blackburn G. Effect of Degree of Weight Loss on Health Benefits. Obes Res. 1995;3(S2):211s–216s.
  • Ryan DH, Yockey SR, Loss W. Improvement in Comorbidity: differences at 5%, 10%, 15%, and Over HHS Public Access. Current Obesity Reports. 2017;6(2):187–194.
  • Unick JL, Beavers D, Jakicic JM, et al. Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the look AHEAD trial. Diabetes Care. 2011;34(10):2152–2157.
  • Singh N, Stewart RAH, Benatar JR. Intensity and duration of lifestyle interventions for long-term weight loss and association with mortality: a meta-analysis of randomised trials. BMJ Open. 2019;9(8):e029966.
  • Khera R, Murad MH, Chandar AK, et al. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events. JAMA. 2016;315(22):2424.
  • Singh AK, Singh R. Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs. Expert Rev Clin Pharmacol. 2020;13(1):53–64.
  • Cosentino C, Marchetti C, Monami M, et al. Efficacy and effects of bariatric surgery in the treatment of obesity: network meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2021;31(10):2815–2824.
  • Ramai D, Singh J, Mohan BP, et al. Influence of the Elipse Intragastric Balloon on Obesity and Metabolic Profile: a Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2021;55(10):10.
  • Vantanasiri K, Matar R, Beran A, et al. Safety of a Procedureless Gastric Balloon for Weight Loss: a Systematic Review and Meta-Analysis. Obes Surg. 2020;30(9):3341–3346.
  • Ogden J, Clementi C, Aylwin S. The impact of obesity surgery and the paradox of control: a qualitative study. Psychol Health. 2006;21(2):273–293.
  • The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–2171.
  • Elfhag K, Rössner S. Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev. 2005;6(1):67–85.
  • Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985;29(1):71–83.
  • Bandura A. Self-Efficacy. Corsini Encycl Psychol. 2010 January 30;1–3. doi:10.1002/9780470479216.CORPSY0836 Published online
  • Wallston KA, Wallston BS, DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Educ Monogr. 1978;6(2):160–170.
  • Dansinger ML, Gleason JA, Griffith JL, et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for Weight Loss and Heart Disease Risk Reduction. JAMA. 2005;293(1):43.
  • Ge L, Sadeghirad B, Ball GDC, et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ. 2020;369. DOI:10.1136/BMJ.M696.
  • Clark JE. Diet, exercise or diet with exercise: comparing the effectiveness of treatment options for weight-loss and changes in fitness for adults (18–65 years old) who are overfat, or obese; systematic review and meta-analysis. J Diabetes Metab Disord. 2015;14(1):31.
  • Nackers LM, Middleton KR, Dubyak PJ, et al. Effects of Prescribing 1,000 versus 1,500 Kilocalories per Day in the Behavioral Treatment of Obesity: a Randomized Trial. Obesity (Silver Spring). 2013;21(12):2481.
  • Iłowiecka K, Glibowski P, Skrzypek M, et al. Dietitian and Psychological Support of Obese Patients Who Have Reduced Their Weight Allows Them to Maintain the Effects. Nutrients. 2021;13(6):2020.
  • Bellicha A, Baak MA, Battista F, et al. Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: an overview of 12 systematic reviews and 149 studies. Obes Rev. 2021;22(S4):S4.
  • McCarthy D, Berg A. Weight Loss Strategies and the Risk of Skeletal Muscle Mass Loss. Nutrients. 2021;13(7):2473.
  • Ho SS, Dhaliwal SS, Hills AP, et al. The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial. BMC Public Health. 2012;12(1):704.
  • Marc-Hernández A, Ruiz-Tovar J, Aracil A, et al. Effects of a High-Intensity Exercise Program on Weight Regain and Cardio-metabolic Profile after 3 Years of Bariatric Surgery: a Randomized Trial. Sci Rep. 2020;10(1):3123.
  • Johnson NA, Sultana RN, Brown WJ, et al. Physical activity in the management of obesity in adults: a position statement from Exercise and Sport Science Australia. J Sci Med Sport. 2021;24(12):1245–1254.
  • Wharton S, Liu A, Pakseresht A, et al. Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada. Obesity. 2019;27(6):917–924.
  • le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389(10077):1399–1409.
  • Moon S, Lee J, Chung HS, et al. Efficacy and Safety of the New Appetite Suppressant, Liraglutide: a Meta-Analysis of Randomized Controlled Trials. Endocrinol Metab. 2021;36(3):647–660.
  • Sahebkar A, Simental-Mendía LE, Ž R, et al. Effect of orlistat on plasma lipids and body weight: a systematic review and meta-analysis of 33 randomized controlled trials. Pharmacol Res. 2017;122:53–65.
  • Sumithran P, Benefit-Risk PJ. Assessment of Orlistat in the Treatment of Obesity. Drug Saf. 2014;37(8):597–608.
  • Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med. 1995;98(2):115–117.
  • Andrés-Imaz A, Martí-Gelonch L, Eizaguirre-Letamendia E, et al. Incidence and risk factors for de novo cholelithiasis after bariatric surgery. Cir Esp. 2020;99(9):648–654.
  • Stokes CS, Gluud LL, Casper M, et al. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol. 2014;12(7):7.
  • Maa S, Salman A, US M, et al. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study. Surg Endosc. 2022. DOI:10.1007/S00464-021-08980-3. Published online.
  • Moore RL, Seger MV, Garber SM, et al. Clinical safety and effectiveness of a swallowable gas-filled intragastric balloon system for weight loss: consecutively treated patients in the initial year of U.S. commercialization. Surg Obes Relat Dis. 2019;15(3):417–423.
  • Sullivan S, Swain J, Woodman G, et al. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss. Surg Obes Relat Dis. 2018;14(12):1876–1889.
  • Giulietti C, Menculini G, Brufani F, et al. Psychiatric Comorbidity in Bariatric Surgery: a Retrospective Study in a General Hospital. Psychiatr Danub. 2021;33(Suppl9): 75–79. Accessed September 30, 2021. https://pubmed.ncbi.nlm.nih.gov/34559782/
  • Oliver A, Hooper S, Lau R, et al. Effect of a multidisciplinary rehabilitation program for patients receiving weight management interventions on eating behaviours and health-related quality of life. Obes Res Clin Pract. 2021;15(3):268–274.
  • Yolsuriyanwong K, Thanavachirasin K, Sasso K, et al. Effectiveness, Compliance, and Acceptability of Preoperative Weight Loss with a Liquid Very Low-Calorie Diet Before Bariatric Surgery in Real Practice. Obes Surg. 2019;29(1):54–60.
  • Van Nieuwenhove Y, Dambrauskas Z, Campillo-Soto A, et al. Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg. 2011;146(11):1300–1305.
  • In G, Taskin HE, Al M, et al. Comparison of 12-Week Fitness Protocols Following Bariatric Surgery: aerobic Exercise Versus Aerobic Exercise and Progressive Resistance. Obes Surg. 2021;31(4):1475–1484.
  • Gils Contreras A, Bonada Sanjaume A, Becerra-Tomás N, et al. Adherence to Mediterranean Diet or Physical Activity After Bariatric Surgery and Its Effects on Weight Loss, Quality of Life, and Food Tolerance. Obes Surg. 2020;30(2):687–696.
  • Klein S, Fontana L, Young VL, et al. Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease. N Engl J Med. 2004;350(25):2549–2557.
  • Gibas-Dorna M, Szulińska M, Turkowski P, et al. The Effect of VASER Abdominal Liposuction on Metabolic Profile in Overweight Males:. American Journal of Men’s Health. 2016;11(2):284–293.
  • Giugliano G, Nicoletti G, Grella E, et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg. 2004;57(3):190–194.
  • Ng JY, Ahmed S, Zhang CJ. Dietary and herbal supplements for weight loss: assessing the quality of patient information online. Nutr J. 2021;20(1):72.
  • Batsis JA, Apolzan JW, Bagley PJ, et al. A Systematic Review of Dietary Supplements and Alternative Therapies for Weight Loss. Obesity. 2021;29(7):1102–1113.
  • Kidambi S, Batsis JA, Donahoo WT, et al. Dietary supplements and alternative therapies for obesity: a Perspective from The Obesity Society’s Clinical Committee. Obesity. 2021;29(7):1095–1098.
  • Chen J, Chen D, Ren Q, et al. Acupuncture and related techniques for obesity and cardiovascular risk factors: a systematic review and meta-regression analysis. Acupunct Med. 2020;38(4):227–234.
  • Ravussin E, Smith SR, Ferrante AW. Physiology of Energy Expenditure in the Weight-Reduced State. Obesity. 2021;29(S1):S31–S38.
  • Ben-Porat T, Mashin L, Kaluti D, et al. Weight Loss Outcomes and Lifestyle Patterns Following Sleeve Gastrectomy: an 8-Year Retrospective Study of 212 Patients. Obes Surg. 2021;31(11):4836–4845.
  • Wilkinson L, Pacanowski CR, Levitsky D. Three-Year Follow-Up of Participants from a Self-Weighing Randomized Controlled Trial. J Obes. 2017;2017:1–7.
  • Pacanowski CR, Bertz F, Levitsky DA. Daily Self-Weighing to Control Body Weight in Adults. SAGE Open. 2014;4(4):215824401455699.
  • Correa LL, Moretti A, Pam DS, et al. Effectiveness and Safety of a Very Low-Calorie Ketogenic Diet on Weight Regain Following Bariatric Surgery. Obes Surg. 2021;31(12):5383–5390.
  • van Baak MA, Hul G, Astrup A, Saris WH. Physical Activity, Weight Loss, and. Weight Maintenance in the DiOGenes Multicenter Trial. Front Nutr. 2021:8. DOI:10.3389/fnut.2021.683369
  • Hartmann-Boyce J, Theodoulou A, Oke JL, et al. Association between characteristics of behavioural weight loss programmes and weight change after programme end: systematic review and meta-analysis. BMJ. 2021;374:n1840.
  • Lundgren JR, Janus C, Jensen SBK, et al. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. N Engl J Med. 2021;384(18):1719–1730.
  • Brisbois TD, Farmer AP, McCargar LJ. Early markers of adult obesity: a review. Obes Rev. 2012;13(4):347–367.
  • Gordon-Larsen P, The NS, Adair LS. Longitudinal Trends in Obesity in the United States From Adolescence to the Third Decade of Life. Obesity. 2010;18(9):1801–1804.
  • Freedman DS, Goodman AB, King RJ, et al. The Relation of Adiposity Rebound to Subsequent BMI in a Large Electronic Health Record Database. Child Obes. 2021;17(1):51–57.
  • Ziauddeen N, Wilding S, Roderick PJ, et al. Predicting the risk of childhood overweight and obesity at 4–5 years using population-level pregnancy and early-life healthcare data. BMC Med. 2020;18(1):1–15.
  • Rooney BL, Mathiason MA, Schauberger CW. Predictors of Obesity in Childhood, Adolescence, and Adulthood in a Birth Cohort. Matern Child Health J. 2011;15(8):1166–1175.
  • CS DS, Picoito J, Nunes C, et al. Early Individual and Family Predictors of Weight Trajectories From Early Childhood to Adolescence: results From the Millennium Cohort Study. Front Pediatr. 2020;8:8.
  • Mǎrginean CO, Mǎrginean C, Meliţ LE. New Insights Regarding Genetic Aspects of Childhood Obesity: a Minireview. Front Pediatr. 2018;0:271.
  • Goldhaber-Fiebert JD, Rubinfeld RE, Bhattacharya J, et al. The Utility of Childhood and Adolescent Obesity Assessment in Relation to Adult Health. Med Decis Mak. 2013;33(2):163–175.
  • Spolidoro JV, Filho MLP, Vargas LT, et al. Waist circumference in children and adolescents correlate with metabolic syndrome and fat deposits in young adults. Clin Nutr. 2013;32(1):93–97.
  • Jago R, Mendoza JA, Chen T, et al. Longitudinal associations between BMI, waist circumference, and cardiometabolic risk in US youth: monitoring implications. Obesity. 2013;21(3):E271–E279.
  • Bassali R, Waller JL, Gower B, et al. Utility of waist circumference percentile for risk evaluation in obese children. Int J Pediatr Obes. 2010;5(1):97.
  • Savva SC, Tornaritis M, Savva ME, et al. Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord. 2000;24(11):1453–1458.
  • Podnar H, Jurić P, Karuc J, et al. Comparative effectiveness of school‐based interventions targeting physical activity, physical fitness or sedentary behaviour on obesity prevention in 6‐ to 12‐year‐old children: a systematic review and meta‐analysis. Obes Rev. 2021;22(2):2.
  • Li B, Pallan M, Liu WJ, et al. The CHIRPY DRAGON intervention in preventing obesity in Chinese primary-school–aged children: a cluster-randomised controlled trial. Basu S, ed. PLOS Med. 2019;16(11):e1002971.
  • Taghizadeh S, Farhangi MA. The effectiveness of pediatric obesity prevention policies: a comprehensive systematic review and dose–response meta-analysis of controlled clinical trials. J Transl Med. 2020;18(1):480.
  • Cuda SE, Censani M. Pediatric Obesity Algorithm: a Practical Approach to Obesity Diagnosis and Management. Front Pediatr. 2018;6(JAN). DOI:10.3389/FPED.2018.00431
  • Gutin B, Barbeau P, Owens S, et al. Effects of exercise intensity on cardiovascular fitness, total body composition, and visceral adiposity of obese adolescents. Am J Clin Nutr. 2002;75(5):818–826.
  • Fang K, Mu M, Liu K, et al. Screen time and childhood overweight/obesity: a systematic review and meta‐analysis. Child Care Health Dev. 2019;45(5):744–753.
  • Kawai M. Disruption of the circadian rhythms and its relationship with pediatric obesity. Pediatr Int. 2022;64(1):1.
  • Askie LM, Espinoza D, Martin A, et al. Interventions commenced by early infancy to prevent childhood obesity—The EPOCH Collaboration: an individual participant data prospective meta‐analysis of four randomized controlled trials. Pediatr Obes. 2020;15(6):6.
  • Tomayko EJ, Tovar A, Fitzgerald N, et al. Parent Involvement in Diet or Physical Activity Interventions to Treat or Prevent Childhood Obesity: an Umbrella Review. Nutrients. 2021;13(9):3227.
  • Mead E, Atkinson G, Richter B, et al. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2016;2016:11.
  • Czepiel KS, Perez NP, Campoverde Reyes KJ, et al. Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US. Front Endocrinol (Lausanne). 2020;290.
  • Lustig RH, Hinds PS, Ringwald-Smith K, et al. Octreotide Therapy of Pediatric Hypothalamic Obesity: a Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2003;88(6):2586–2592.
  • Zachurzok A, Ranke MB, Flehmig B, et al. Relative leptin deficiency in children with severe early-onset obesity (SEOO) – results of the Early-onset Obesity and Leptin – German-Polish Study (EOL-GPS). J Pediatr Endocrinol Metab. 2020;33(2):255–263.
  • Ryan PM, Seltzer S, Hayward NE, et al. Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: a Meta-Analysis. J Pediatr. 2021;236:137–147.e13.
  • Liang S, Xue J, Li G. Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency. Lipids Health Dis. 2018;17(1):1.
  • Black JA, White B, Viner RM, et al. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. Obes Rev. 2013;14(8):634–644.
  • Calcaterra V, Cena H, Pelizzo G, et al. Bariatric Surgery in Adolescents: to Do or Not to Do? Children. 2021;8(6):453.
  • Lee JC, Bernardi LA, Boots CE. The association of euploid miscarriage with obesity. F&S Reports. 2020;1(2):142–148.
  • Fabozzi G, Cimadomo D, Allori M, et al. Maternal body mass index associates with blastocyst euploidy and live birth rates: the tip of an iceberg? Reprod Biomed Online. 2021;43(4):645–654.
  • van Duijn L, Rousian M, Laven JSE, et al. Periconceptional maternal body mass index and the impact on post-implantation (sex-specific) embryonic growth and morphological development. Int J Obes. 2021;45(11):2369–2376.
  • Bautista-Castaño I, Henriquez-Sanchez P, Alemán-Perez N, et al. Maternal Obesity in Early Pregnancy and Risk of Adverse Outcomes. PLoS One. 2013;8(11):80410.
  • Nohr EA, Wolff S, Kirkegaard H, et al. Cause-Specific Stillbirth and Neonatal Death According to Prepregnancy Obesity and Early Gestational Weight Gain: a Study in the Danish National Birth Cohort. Nutrients. 2021;13(5):1676.
  • Chang R, Mei H, Zhang Y, et al. Early childhood body mass index trajectory and overweight/obesity risk differed by maternal weight status. Eur J Clin Nutr. 2022;76(3):450–455.
  • Yang Z, Phung H, Freebairn L, et al. Contribution of maternal overweight and obesity to the occurrence of adverse pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2019;59(3):367–374.
  • Jadresić L, Au H, Woodhouse C, et al. Pre-pregnancy obesity and risk of congenital abnormalities of the kidney and urinary tract (CAKUT)—systematic review, meta-analysis and ecological study. Pediatr Nephrol. 2021;36(1):119–132.
  • Zhang L, Zhang Y, Li Z, et al. Maternal periconceptional body mass index and risk for neural tube defects: results from a large cohort study in China. J Matern Neonatal Med. 2021;34(2):274–280.
  • American College of Obstetricians and Gynecologists. Obesity in Pregnancy: ACOG Practice Bulletin, Number 230. Obstet Gynecol. 2021;137(6):e128–e144.
  • Cantor AG, Jungbauer RM, McDonagh M, et al. Counseling and Behavioral Interventions for Healthy Weight and Weight Gain in Pregnancy. JAMA. 2021;325(20):2094.
  • Gomes D, von Kries R, Delius M, et al. Late-pregnancy dysglycemia in obese pregnancies after negative testing for gestational diabetes and risk of future childhood overweight: an interim analysis from a longitudinal mother–child cohort study. Myers JE, ed. PLOS Med. 2018;15(10):e1002681.
  • Sun Y, Shen Z, Zhan Y, et al. Effects of pre-pregnancy body mass index and gestational weight gain on maternal and infant complications. BMC Pregnancy Childbirth. 2020;20(1):390.
  • Fan H, Li X, Zheng L, et al. Abdominal obesity is strongly associated with Cardiovascular Disease and its Risk Factors in Elderly and very Elderly Community-dwelling Chinese. Sci Rep. 2016;6(1):6.
  • Leitzmann MF, Moore SC, Koster A, et al. Waist Circumference as Compared with Body-Mass Index in Predicting Mortality from Specific Causes. PLoS One. 2011;6(4):e18582.
  • Batsis JA, Mackenzie TA, Bartels SJ, et al. Diagnostic Accuracy of Body Mass Index to Identify Obesity in Older Adults: NHANES 1999–2004. Int J Obes (Lond). 2016;40(5):761.
  • Tyrovolas S, Panagiotakos D, Georgousopoulou E, et al. Skeletal muscle mass in relation to 10 year cardiovascular disease incidence among middle aged and older adults: the ATTICA study. J Epidemiol Community Health. 2020;74(1):26–31.
  • Cerhan JR, Moore SC, Jacobs EJ, et al. A Pooled Analysis of Waist Circumference and Mortality in 650,000 Adults. Mayo Clin Proc. 2014;89(3):335.
  • Knowles R, Carter J, Jebb SA, et al. Associations of Skeletal Muscle Mass and Fat Mass With Incident Cardiovascular Disease and All‐Cause Mortality: a Prospective Cohort Study of UK Biobank Participants. J Am Heart Assoc. 2021;10(9):9.
  • Donini LM, Pinto A, Giusti AM, et al. Obesity or BMI Paradox? Beneath the Tip of the Iceberg. Front Nutr. 2020; 53.
  • Brown RE, Kuk JL. Age-related Differences in the Consequences of Obesity on Cardiovascular Disease, Type 2 Diabetes, Osteoarthritis, Cancer, Physical Function, Osteoporosis, Cognitive Function, and Mortality Risk in the Elderly. Heal Aging Clin Care Elder. 2014;6:25–32.
  • Liao C-D, Lee P-H, Hsiao D-J, et al. Effects of Protein Supplementation Combined with Exercise Intervention on Frailty Indices, Body Composition, and Physical Function in Frail Older Adults. Nutrients. 2018;10(12):1916.
  • Colleluori G, Villareal DT. Aging, obesity, sarcopenia and the effect of diet and exercise intervention. Exp Gerontol. 2021 September; 155:111561.10.1016/j.exger.2021.111561 Published online
  • Saad F, Yassin A, Doros G, et al. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies. Int J Obes. 2016;40(1):162–170.
  • Vinan-Vega M, Diaz Vico T, Elli EF. Bariatric Surgery in the Elderly Patient: safety and Short-time Outcome. A Case Match Analysis. Obes Surg. 2019;29(3):1007–1011.
  • Elbahrawy A, Bougie A, Loiselle S-E, et al. Medium to long-term outcomes of bariatric surgery in older adults with super obesity. Surg Obes Relat Dis. 2018;14(4):470–476.
  • Martín AS, Sepúlveda M, Guzman F, et al. Surgical Morbidity in the Elderly Bariatric Patient: does Age Matter? Obes Surg. 2019;29(8):2548–2552.
  • Victorzon M, Giordano S. Bariatric surgery in elderly patients: a systematic review. Clin Interv Aging. 2015;10:1627.